{
    "address1": "88 Sidney Street",
    "city": "Cambridge",
    "state": "MA",
    "zip": "02139",
    "country": "United States",
    "phone": "617 649 8600",
    "website": "https://www.agios.com",
    "industry": "Biotechnology",
    "industryDisp": "Biotechnology",
    "sector": "Healthcare",
    "sectorDisp": "Healthcare",
    "longBusinessSummary": "Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism. The company develops PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias; and AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.",
    "fullTimeEmployees": 389,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Mr. Brian M. Goff M.B.A.",
            "age": 53,
            "title": "CEO & Director",
            "yearBorn": 1969,
            "fiscalYear": 2022,
            "totalPay": 1230972,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Cecilia  Jones",
            "age": 47,
            "title": "Chief Financial Officer",
            "yearBorn": 1975,
            "fiscalYear": 2022,
            "totalPay": 403356,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. James William Burns",
            "age": 44,
            "title": "Corp. Sec. & Chief Legal Officer",
            "yearBorn": 1978,
            "fiscalYear": 2022,
            "totalPay": 660325,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Sarah  Gheuens M.D., Ph.D.",
            "age": 42,
            "title": "Chief Medical Officer and Head of R&D",
            "yearBorn": 1980,
            "fiscalYear": 2022,
            "totalPay": 769203,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Lewis Clayton Cantley Ph.D.",
            "age": 73,
            "title": "Co-Founder & Member of Scientific Advisory Board",
            "yearBorn": 1949,
            "fiscalYear": 2017,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.",
            "age": 76,
            "title": "Co-Founder & Member of Scientific Advisory Board",
            "yearBorn": 1946,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Craig B. Thompson M.D.",
            "age": 69,
            "title": "Co-Founder & Chairman of Scientific Advisory Board",
            "yearBorn": 1953,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Shin-San  Su Ph.D.",
            "age": 66,
            "title": "Co-Founder & Member of Scientific Advisory Board",
            "yearBorn": 1956,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. T. J. Washburn Jr.",
            "age": 41,
            "title": "Principal Accounting Officer",
            "yearBorn": 1981,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Clive  Patience Ph.D.",
            "age": 58,
            "title": "Chief Technical Operations Officer",
            "yearBorn": 1964,
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 5,
    "boardRisk": 2,
    "compensationRisk": 6,
    "shareHolderRightsRisk": 7,
    "overallRisk": 5,
    "governanceEpochDate": 1690848000,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 26.59,
    "open": 26.62,
    "dayLow": 26.42,
    "dayHigh": 27.29,
    "regularMarketPreviousClose": 26.59,
    "regularMarketOpen": 26.62,
    "regularMarketDayLow": 26.42,
    "regularMarketDayHigh": 27.29,
    "payoutRatio": 0.0,
    "beta": 0.952892,
    "forwardPE": -5.2778864,
    "volume": 199504,
    "regularMarketVolume": 199504,
    "averageVolume": 411635,
    "averageVolume10days": 298710,
    "averageDailyVolume10Day": 298710,
    "bid": 26.95,
    "ask": 27.11,
    "bidSize": 800,
    "askSize": 800,
    "marketCap": 1503288832,
    "fiftyTwoWeekLow": 21.07,
    "fiftyTwoWeekHigh": 34.76,
    "priceToSalesTrailing12Months": 74.61601,
    "fiftyDayAverage": 26.8348,
    "twoHundredDayAverage": 26.45935,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 879669056,
    "profitMargins": 0.0,
    "floatShares": 51682042,
    "sharesOutstanding": 55580800,
    "sharesShort": 5960568,
    "sharesShortPriorMonth": 6226025,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.1069,
    "heldPercentInsiders": 0.0141199995,
    "heldPercentInstitutions": 1.05906,
    "shortRatio": 16.64,
    "shortPercentOfFloat": 0.1082,
    "impliedSharesOutstanding": 55739300,
    "bookValue": 17.3,
    "priceToBook": 1.5589596,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "netIncomeToCommon": -210044992,
    "trailingEps": -3.8,
    "forwardEps": -5.11,
    "pegRatio": -0.11,
    "enterpriseToRevenue": 43.663,
    "enterpriseToEbitda": -2.396,
    "52WeekChange": 0.044134736,
    "SandP52WeekChange": 0.09306288,
    "exchange": "NMS",
    "quoteType": "EQUITY",
    "symbol": "AGIO",
    "underlyingSymbol": "AGIO",
    "shortName": "Agios Pharmaceuticals, Inc.",
    "longName": "Agios Pharmaceuticals, Inc.",
    "firstTradeDateEpochUtc": 1374672600,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "uuid": "52f076ec-0de6-382e-b01b-3ddfa165dcb4",
    "messageBoardId": "finmb_46539787",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 26.97,
    "targetHighPrice": 46.0,
    "targetLowPrice": 32.0,
    "targetMeanPrice": 38.83,
    "targetMedianPrice": 40.5,
    "recommendationMean": 2.1,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 6,
    "totalCash": 702566016,
    "totalCashPerShare": 12.604,
    "ebitda": -367183008,
    "totalDebt": 78946000,
    "quickRatio": 12.782,
    "currentRatio": 13.733,
    "totalRevenue": 20147000,
    "debtToEquity": 8.187,
    "revenuePerShare": 0.365,
    "returnOnAssets": -0.20030001,
    "returnOnEquity": -0.20116,
    "grossProfits": 12536000,
    "freeCashflow": -182100368,
    "operatingCashflow": -299444992,
    "revenueGrowth": 0.202,
    "grossMargins": 1.29076,
    "ebitdaMargins": 0.0,
    "operatingMargins": -18.5921,
    "financialCurrency": "USD",
    "trailingPegRatio": null,
    "parent_etfs": [
        "AGNG"
    ]
}